Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
Biovault is more than a biobank. We are a bioresource offering stem cell processing, allografts, support services and consultancy, as well as biobanking you can trust.
In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.
Everyone should have full and equal access to science education and careers, but do they? February 11th is the United Nations International Day of Women and Girls in Science. We check up on equality of access in the UK and at Biovault.
